Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Dichek

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Circulation Research|October 26, 1999
A mouse model of arterial gene transfer: antigen-specific immunity is a minor determinant of the early loss of adenovirus-mediated transgene expressionG Vassalli, R Agah, R Qiao, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 10, 2001
Inclusion of the E3 region in an adenoviral vector decreases inflammation and neointima formation after arterial gene transferS Wen, R M Driscoll, D B Schneider, et al.
Human Gene Therapy|May 15, 1998
Adenoviral gene transfer in arteries of hypercholesterolemic nonhuman primatesD B Schneider, C A Fly, D A Dichek, et al.
Circulation Research|September 1, 1995
Endothelium-specific in vivo gene transferA H Schulick, G Dong, K D Newman, et al.
Journal of Vascular Surgery|March 9, 1999
Adventitial delivery minimizes the proinflammatory effects of adenoviral vectorsD B Schneider, A B Sassani, G Vassalli, et al.
Circulation Research|November 1, 1993
In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteriesS W Lee, B C Trapnell, J J Rade, et al.
Circulation|January 15, 1996
Enhanced in vivo antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectorsD A Dichek, J Anderson, A B Kelly, et al.
Circulation Research|February 1, 1992
Genetically engineered endothelial cells remain adherent and viable after stent deployment and exposure to flow in vitroM Y Flugelman, R Virmani, M B Leon, et al.
Circulation Research|May 29, 2000
Cardiovascular overexpression of transforming growth factor-beta(1) causes abnormal yolk sac vasculogenesis and early embryonic deathR Agah, K S Prasad, R Linnemann, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 10, 2000
Second-generation adenoviral vectors do not prevent rapid loss of transgene expression and vector DNA from the arterial wallS Wen, D B Schneider, R M Driscoll, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Circulation Research|October 26, 1999
A mouse model of arterial gene transfer: antigen-specific immunity is a minor determinant of the early loss of adenovirus-mediated transgene expressionG Vassalli, R Agah, R Qiao, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 10, 2001
Inclusion of the E3 region in an adenoviral vector decreases inflammation and neointima formation after arterial gene transferS Wen, R M Driscoll, D B Schneider, et al.
Human Gene Therapy|May 15, 1998
Adenoviral gene transfer in arteries of hypercholesterolemic nonhuman primatesD B Schneider, C A Fly, D A Dichek, et al.
Circulation Research|September 1, 1995
Endothelium-specific in vivo gene transferA H Schulick, G Dong, K D Newman, et al.
Journal of Vascular Surgery|March 9, 1999
Adventitial delivery minimizes the proinflammatory effects of adenoviral vectorsD B Schneider, A B Sassani, G Vassalli, et al.
Circulation Research|November 1, 1993
In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteriesS W Lee, B C Trapnell, J J Rade, et al.
Circulation|January 15, 1996
Enhanced in vivo antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectorsD A Dichek, J Anderson, A B Kelly, et al.
Circulation Research|February 1, 1992
Genetically engineered endothelial cells remain adherent and viable after stent deployment and exposure to flow in vitroM Y Flugelman, R Virmani, M B Leon, et al.
Circulation Research|May 29, 2000
Cardiovascular overexpression of transforming growth factor-beta(1) causes abnormal yolk sac vasculogenesis and early embryonic deathR Agah, K S Prasad, R Linnemann, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 10, 2000
Second-generation adenoviral vectors do not prevent rapid loss of transgene expression and vector DNA from the arterial wallS Wen, D B Schneider, R M Driscoll, et al.
Pageof 6